Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.
- Status
- TERMINATED
- Phase
- PHASE1
FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian
- Status
- COMPLETED
- Phase
- PHASE2